bioMérieux will be awarded up to EUR54.5 million by France's Agence de l'Innovation Industrielle for molecular biology research

28-Nov-2006

bioMérieux announced that it will be awarded up to EUR54.5 million over the next ten years by France's Agence de l'Innovation Industrielle to help fund the "Advanced diagnostics and New therapeutic Approaches" (ADNA) program, led by Mérieux Alliance. Of this amount, EUR25.6 million will be in the form of grants and EUR28.9 million in the form of loans. The financing is subject to approval by the European Union, which is expected to make a decision in the second quarter of 2007.

The ADNA program aims to develop personalized medical solutions for cancer, infectious diseases and rare genetic diseases. Four strategically aligned partners, bioMérieux, Généthon, GenoSafe® and Transgene, have teamed up to meet the challenge. An initial partnership between bioMérieux and Ipsen in oncology research has given the project an additional boost.

Over the next ten years, the assistance provided by the agency will help finance programs designed to:

* Find, identify and validate biomarkers. The identification of biomarkers shall help scientists to develop diagnostic tests for earlier disease detection, determine appropriate treatments and monitor treatment response in patients.

* Develop new molecular diagnostic platforms to perform high-value-added analyses of infectious diseases and certain types of cancer.

Other news from the department business & finance

Most read news

More news from our other portals

All FT-IR spectrometer manufacturers at a glance

See the theme worlds for related content

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures
View topic world
Topic world Diagnostics

Topic world Diagnostics

Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.

1 products
1 whitepaper
1 brochures